PZENA INVESTMENT MANAGM-CL A (PZN)

US74731Q1031 - Common Stock

9.65  +0.04 (+0.42%)

After market: 9.65 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PZN. PZN was compared to 210 industry peers in the Capital Markets industry. PZN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PZN has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

In the past year PZN was profitable.
PZN had positive earnings in each of the past 5 years.
PZN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 4.61%
ROE 32.1%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of PZN has grown nicely.
In the last couple of years the Operating Margin of PZN has grown nicely.
Industry RankSector Rank
OM 48.23%
PM (TTM) 6.5%
GM N/A
OM growth 3Y10.34%
OM growth 5Y17.53%
PM growth 3Y10.62%
PM growth 5Y2.89%
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

The number of shares outstanding for PZN has been increased compared to 1 year ago.
The debt/assets ratio for PZN has been reduced compared to a year ago.

2.2 Solvency

There is no outstanding debt for PZN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. Growth

3.1 Past

PZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.57%.
Measured over the past years, PZN shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.14% on average per year.
The Revenue has been growing slightly by 3.60% in the past year.
PZN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.98% yearly.
EPS 1Y (TTM)-28.57%
EPS 3Y5.03%
EPS 5Y-1.14%
EPS growth Q2Q-44.44%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y9.08%
Revenue growth 5Y12.98%
Revenue growth Q2Q-12.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.32%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.79, the valuation of PZN can be described as correct.
PZN is valuated rather cheaply when we compare the Price/Earnings ratio to 24.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.79
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.59

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

PZN has a Yearly Dividend Yield of 1.25%.
Compared to an average S&P500 Dividend Yield of 2.41, PZN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.25%

5.2 History

The dividend of PZN decreases each year by -12.64%.
PZN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-12.64%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

4.08% of the earnings are spent on dividend by PZN. This is a low number and sustainable payout ratio.
The Dividend Rate of PZN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP4.08%
EPS Next 2YN/A
EPS Next 3YN/A

PZENA INVESTMENT MANAGM-CL A

NYSE:PZN (10/28/2022, 7:04:00 PM)

After market: 9.65 0 (0%)

9.65

+0.04 (+0.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap710.99M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 13.79
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 32.1%
ROCE
ROIC
ROICexc
ROICexgc
OM 48.23%
PM (TTM) 6.5%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y5.03%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.6%
Revenue growth 3Y9.08%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y